Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) CFO Robert O’hare sold 79,039 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $70.01, for a total transaction of $5,533,520.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Robert O’hare also recently made the following trade(s):
- On Friday, November 22nd, Robert O’hare sold 11,218 shares of Affirm stock. The stock was sold at an average price of $70.00, for a total value of $785,260.00.
- On Monday, November 11th, Robert O’hare sold 100,938 shares of Affirm stock. The shares were sold at an average price of $55.00, for a total value of $5,551,590.00.
Affirm Price Performance
Shares of NASDAQ AFRM opened at $68.37 on Thursday. The firm has a market capitalization of $21.47 billion, a P/E ratio of -48.15 and a beta of 3.47. The company has a quick ratio of 12.60, a current ratio of 12.60 and a debt-to-equity ratio of 2.50. The stock’s 50-day simple moving average is $47.84 and its two-hundred day simple moving average is $37.25. Affirm Holdings, Inc. has a twelve month low of $22.25 and a twelve month high of $70.20.
Analyst Ratings Changes
Several research analysts recently commented on AFRM shares. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $46.00 target price on shares of Affirm in a research report on Friday, October 4th. Mizuho upped their price target on Affirm from $65.00 to $69.00 and gave the company an “outperform” rating in a research note on Tuesday, November 19th. Barclays increased their target price on Affirm from $64.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday. Bank of America upped their price target on Affirm from $50.00 to $74.00 and gave the stock a “buy” rating in a research report on Friday, November 22nd. Finally, JPMorgan Chase & Co. increased their price objective on Affirm from $47.00 to $56.00 and gave the company an “overweight” rating in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $51.13.
Check Out Our Latest Stock Report on Affirm
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in AFRM. Tidal Investments LLC increased its position in Affirm by 208.6% during the 3rd quarter. Tidal Investments LLC now owns 21,775 shares of the company’s stock valued at $889,000 after buying an additional 14,720 shares in the last quarter. Arete Wealth Advisors LLC bought a new stake in shares of Affirm in the 3rd quarter worth $244,000. Y Intercept Hong Kong Ltd purchased a new position in shares of Affirm in the 3rd quarter worth $1,618,000. Main Management ETF Advisors LLC purchased a new position in shares of Affirm in the 3rd quarter worth $2,629,000. Finally, XTX Topco Ltd lifted its position in Affirm by 25.5% during the third quarter. XTX Topco Ltd now owns 54,032 shares of the company’s stock valued at $2,206,000 after purchasing an additional 10,970 shares in the last quarter. Hedge funds and other institutional investors own 69.29% of the company’s stock.
About Affirm
Affirm Holdings, Inc operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.
Further Reading
- Five stocks we like better than Affirm
- What is the Hang Seng index?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Compound Interest and Why It Matters When Investing
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Canadian Penny Stocks: Can They Make You Rich?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Affirm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm and related companies with MarketBeat.com's FREE daily email newsletter.